West Pharmaceutical Services (WST) Shares Outstanding (Weighted Average) (2009 - 2026)

West Pharmaceutical Services has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $72.0 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $72.0 million, down 0.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $72.0 million (down 0.69% YoY), and the FY2025 annual result was $72.3 million, down 0.96% from the prior year.
• Shares Outstanding (Weighted Average) came in at $72.0 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $72.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $74.5 million in Q1 2023 to a low of $72.0 million in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $73.5 million (2024), against an average of $73.4 million.
• Across the five-year window, Shares Outstanding (Weighted Average) gained 0.68% in 2022 and retreated 2.02% in 2024, its largest moves.
• West Pharmaceutical Services' Shares Outstanding (Weighted Average) stood at $74.4 million in 2022, then decreased by 0.13% to $74.3 million in 2023, then dropped by 1.75% to $73.0 million in 2024, then decreased by 0.96% to $72.3 million in 2025, then decreased by 0.41% to $72.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $72.0 million (Q1 2026), $72.3 million (Q4 2025), and $72.3 million (Q3 2025), per Business Quant data.